AnalystsNathan TreybeckNathan Treybeck's Stock Forecasts
AnalystsNathan Treybeck
Sectors:
Analyst Ranking
Top 34%
#1730 out of 5116 analysts
Average Return
+7.35%
Win Rate
53%8 out of 15
Risk vs Reward
Poor
Good
Nathan Treybeck's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | +121.48% | $40.55 | $89.81 | 2023-12-13 - 2024-12-12 | Strong Buy |
Procept Biorobotics CorpPRCT | +77.90% | $48.60 | $86.46 | 2024-01-09 - 2025-01-08 | Strong Buy |
Irhythm Technologies IncIRTC | +43.39% | $131.12 | $188.01 | 2025-05-02 - 2025-11-28 | Strong Buy |
Procept Biorobotics CorpPRCT | +38.88% | $33.90 | $47.08 | 2023-01-12 - 2024-01-11 | Strong Buy |
Irhythm Technologies IncIRTC | +13.97% | $164.97 | $188.01 | 2025-08-01 - 2025-11-28 | Strong Buy |
Nathan Treybeck Analyst Color
Get additional color on Nathan Treybeck's coverage of popular stocks
Nathan Treybeck's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lemaitre Vascular IncLMAT | 2 | Hold | $93.00 | +12.12% | Maintains | 23 days ago |
Procept Biorobotics CorpPRCT | 9 | Strong Buy | $51.00 | +60.98% | Maintains | 25 days ago |
Integer Holdings CorpITGR | 4 | Hold | $80.00 | +10.83% | Downgrades | a month ago |
Resmed IncRMD | 1 | Hold | $280.00 | +9.45% | Initiates Coverage On | 2 months ago |
Irhythm Technologies IncIRTC | 5 | Strong Buy | $180.00 | -4.26% | Maintains | 4 months ago |
Nevro CorpNVRO | 4 | Hold | $4.00 | -31.51% | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.